Iskra Pusic

Dr. Iskra Pusic is Associate Professor in the Division of Oncology, Department of Internal Medicine, at Washington University School of Medicine in St. Louis, MO. Dr. Pusic’s research focuses on long-term complications after allogeneic hematopoietic cell transplantation, particularly Graft-versus-Host Disease (GvHD) and survivorship. Dr. Pusic is a member of the Chronic GvHD Consortium, Clinical Trials Network and Center for International Blood and Marrow Transplant Research - GvHD and Late Effects Working Committees. She was actively involved in the Steering Committee for 2014 and 2021 NIH Chronic GvHD Consensus Development Projects on etiology and prevention of chronic GvHD, and measuring therapeutic response in chronic GvHD trials. She has been a principal investigator on multiple institutional studies and co-investigator on several large multicenter studies focusing on both acute and chronic GvHD. Dr. Pusic was a co-author on a recent Nature publication suggesting that SARS-CoV-2 infection induces a robust antigen-specific, long-lived humoral immune response in humans.